We are live on ! Find out more
TRV

Third Rock Ventures Portfolio holdings

AUM $1.07B
1-Year Est. Return 170.23%
This Fund
S&P 500
This Quarter Est. Return
+52.86%
1 Year Est. Return
+170.23%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$938M
AUM Growth
-$285M
Cap. Flow
-$593M
Cap. Flow %
-63.23%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$344M
2
BLUE
bluebird bio
BLUE
+$111M
3
SAGE
Sage Therapeutics
SAGE
+$82M
4
LRMR icon
Larimar Therapeutics
LRMR
+$55.4M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAGE
1
DELISTED
Sage Therapeutics
SAGE
$491M 52.36%
9,773,073
-1,907,935
-16% -$82M
FMI
2
DELISTED
Foundation Medicine, Inc.
FMI
$237M 25.28%
4,927,234
– –
LRMR icon
3
Larimar Therapeutics
LRMR
$398M
$166M 17.75%
350,170
-116,667
-25% -$55.4M
CARM
4
DELISTED
Carisma Therapeutics
CARM
$43.2M 4.61%
242,080
– –
AGIO icon
5
Agios Pharmaceuticals
AGIO
$2.38B
– –
-3,070,090
Closed -$344M
BLUE
6
DELISTED
bluebird bio
BLUE
– –
-93,802
Closed -$111M

Similar funds

AH
Achievement Holdings Chicago, Illinois $1.2B AUM 9.2% 1-Year Est. Return
GHF
Good Harbor Financial Barrington, Illinois $916M AUM 5.96% 1-Year Est. Return
CWA
Constellation Wealth Advisors New York $903M AUM 2.38% 1-Year Est. Return
RI
Relational Investors San Diego, California $840M AUM 0.57% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
F
FutureAdvisor San Francisco, California $617M AUM 6.57% 1-Year Est. Return
MCC
Mid Continent Capital Chicago, Illinois $1.54B AUM 0.7% 1-Year Est. Return
OA
OFI Advisors Philadelphia, Pennsylvania $1.55B AUM 1.44% 1-Year Est. Return

Third Rock Ventures's Q1 2015 Portfolio in Review

As of Q1 2015, Third Rock Ventures held 6 positions worth $938M, down 23% from $1.22B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Third Rock Ventures withdrew a net $593M in Q1 2015, closing 2 positions and reducing 2 holdings. Its most notable exit was Agios Pharmaceuticals, an estimated $344M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Third Rock Ventures's biggest Q1 2015 reduction was Sage Therapeutics, cutting an estimated $82M.
  • Third Rock Ventures fully exited Agios Pharmaceuticals in Q1 2015, selling an estimated $344M.
  • Third Rock Ventures's ten largest holdings make up 100% of its $938M portfolio in Q1 2015.
  • Third Rock Ventures opened 0 new positions and closed 2 in Q1 2015.
  • Third Rock Ventures's portfolio value fell 23% quarter-over-quarter to $938M.

Based on Third Rock Ventures's 13F filing for Q1 2015, filed 29 Apr 2015.